There are 2934 resources available
Active management of patient’s comorbidities including cardiac toxicity
Presenter: Anne-Marie Dingemans
Session: Beyond initial radical treatment of patients with lung cancer
Resources:
Slides
Proffered Paper – Translational research - Invited Discussant 1874O and LBA77
Presenter: Jose Lopez-Martin
Session: Proffered Paper – Translational research
Resources:
Slides
1883 - EONS - Safe administration of 5-fluorouracil with elastomeric pumps
Presenter: Paul Sessink
Session: EONS 12: Patient safety in cancer care
Resources:
Abstract
Slides
Webcast
4204 - Assessment of Cardiotoxicity (CT) Associated with Doxorubicin (dox) in Patients (pts) with Advanced Soft Tissue Sarcoma (STS) in a Phase 3 Randomized Trial
Presenter: Robin Lewis Jones
Session: Proffered Paper – Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1872 - Long term follow-up (F/U) report of symptomatic cardiac events (SCEs) in 2,809 breast cancer (BC) patients (pts) treated with adjuvant trastuzumab (T) in real world (RW) practice
Presenter: Serena Di Cosimo
Session: Proffered Paper – Supportive and palliative care
Resources:
Abstract
Slides
Webcast
EONS - Patient safety and healthcare quality
Presenter: Ciara Kirke
Session: EONS 12: Patient safety in cancer care
Resources:
Slides
Webcast
EONS - Being safe - Feeling safe: The importance of supporting carers - Barriers/ enablers
Presenter: Rebecca Verity
Session: EONS 12: Patient safety in cancer care
Resources:
Slides
Webcast
6571 - Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130
Presenter: Hope Rugo
Session: Proffered Paper - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
1103 - KEYNOTE-119: Phase 3 study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple-negative breast cancer (mTNBC)
Presenter: Javier Cortés
Session: Proffered Paper - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
6255 - Trilaciclib improves overall survival when given with gemcitabine/carboplatin (GC) in patients with metastatic triple negative breast cancer (mTNBC) in a randomized phase 2 trial.
Presenter: Joyce O'Shaughnessy
Session: Proffered Paper - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast